Concomitant reduction of matrix metalloproteinase-2 secretion and intracellular reactive oxygen species following anti-sense inhibition of telomerase activity in PC-3 prostate carcinoma cells

Molecular and Cellular Biochemistry

Volumn 273, Issue 1-2, 2005, Pages 109-116

  Shariftabrizi, Ahmad ^a   Khorramizadeh, Mohammad Reza ^a   Saadat, Farshid ^a   Alimoghadam, Kamran ^a   Safavifar, Farnaz ^a   Ebrahimkhani, Mohammad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Intracellular reactive oxygen species; Matrix metalloproteinase 2; Nitric oxide; RNA component of telomerase

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DICHLORODIHYDROFLUORESCEIN DIACETATE; FUGENE 6; GELATINASE A; GRIESS REAGENT; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REAGENT; TELOMERASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; INVASIVE CARCINOMA; MALE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PROSTATE CARCINOMA; PROTEIN SECRETION;

APOPTOSIS; DNA-BINDING PROTEINS; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; OLIGONUCLEOTIDES, ANTISENSE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 20044388366     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-8158-7     Document Type: Article

References (46)

1. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266(5193): 2011-2015, 1994 1:CAS:528:DyaK2MXisl2lu7g%3D
2. Kim NW: Clinical implications of telomerase in cancer. Eur J Cancer 33(5): 781-786, 1997 10.1016/S0959-8049(97)00057-9
3. Engelhardt M, Drullinsky P, Guillem J, Moore MA: Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 3(11): 1931-1941, 1997 1:CAS:528:DyaK2sXns1Ogsrc%3D
4. Lin Y, Miyamoto H, Fujinami K, Uemura H, Hosaka M, Iwasaki Y, Kubota Y: Telomerase activity in human bladder cancer. Clin Cancer Res 2(6): 929-932, 1996 1:STN:280:DyaK1M%2FjsFWjsg%3D%3D
5. Zhang DK, Ngan HY, Cheng RY, Cheung AN, Liu SS, Tsao SW: Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer. Eur J Cancer 35(1): 154-160, 1999 10.1016/ S0959-8049(98)00303-7
6. Kanamaru T, Yamamoto M, Morita Y, Itoh T, Kuroda Y, Hisatomi H: Clinical implications of telomerase activity in resected hepatocellular carcinoma. Int J Mol Med 4(3): 267-271, 1999 1:STN:280:DyaK1Mzls1Sksg%3D%3D
7. Kakeji Y, Maehara Y, Koga T, Shibahara K, Kabashima A, Tokunaga E, Sugimachi K: Gastric cancer with high telomerase activity shows rapid development and invasiveness. Oncol Rep 8(1): 107-110, 2001 1:STN:280:DC%2BD3M7ivFOqtQ%3D%3D
8. Mokbel KM, Parris CN, Ghilchik M, Amerasinghe CN, Newbold RF: Telomerase activity and lymphovascular invasion in breast cancer. Eur J Surg Oncol 26(1): 30-33, 2000 10.1053/ejso.1999.0736
9. Simon M, Park TW, Leuenroth S, Hans VH, Loning T, Schramm J: Telomerase activity and expression of the telomerase catalytic subunit, hTR, in meningioma progression. J Neurosurg 92(5): 832-840, 2000 1:CAS:528:DC%2BD3cXjsVerurc%3D
10. Sato N, Maehara N, Mizumoto K, Nagai E, Yasoshima T, Hirata K, Tanaka M: Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion. Cancer 91(3): 496-504, 2001 10.1002/ 1097-0142(20010201)91:3<496::AID-CNCR1028>3.0.CO;2-0
11. Mitsui A, Kuwabara Y, Iwase H, Mitani M, Shinoda N, Sato A, Toyama T, Sugiura M, Suzuki T, Kato J, Fujii Y: Telomerase activity in esophageal squamous cell carcinoma: Down-regulation by chemotherapeutic agent. J Surg Oncol 79(1): 37-45, 2002 10.1002/jso.10025
12. Yang SM, Fang DC, Yang JL, Liang GP: Effects of anti-sense human telomerase RNA on malignant phenotypes of gastric cancer. J Gastreoenterol Hepatol 17(11): 1144-1152, 2002 10.1046/ j.1440-1746.2002.02857.x 10.1046/j.1440-1746.2002.02857.x
13. Rucklidge GJ, Edwardsen K, Bock E: Cell-adhesion molecules and metalloproteinases: A linked role in tumour cell invasiveness. Biochem Soc Trans 22: 63-68, 1994 1:CAS:528:DyaK2cXisVWgtLw%3D
14. Stetler-Stevenson, WG: Type IV collagenases in tumor invasion and metastasis [review]. Cancer Metastasis Rev 9: 289-303, 1990 10.1007/ BF00049520
15. Lakka SS, Gondi CS, Yanamandra N, Dinh DH, Olivero WC, Gujrati M, Rao JS: Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth. Cancer Res 63(10): 2454-2456, 2003 1:CAS:528:DC%2BD3sXjslehsb4%3D
16. Landar A, Darley-Usmar VM: Nitric oxide and cell signaling; modulation of redox tone and protein modification. Amino Acids 25: 313-321, 2003 10.1007/s00726-003-0019-7
17. Bloodsworth A, O'Donnell VB, Freeman BA: Nitric oxide regulation of free radical- and enzyme-mediated lipid and lipoprotein oxidation. Arterioscler Thromb Vasc Biol 20: 1707-1715, 2000 1:CAS:528:DC%2BD3cXlsFGnsb4%3D
18. Orucevic A, Bechberger J, Green AM, Shapiro RA, Billar TR, Lala Pk: Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor cell invasiveness. Int J Cancer 81(6): 889-896, 1999 10.1002/ (SICI)1097-0215(19990611)81:6<889::AID-IJC9>3.0.CO;2-2
19. Pfeilschifter J, Eberhardt W, Huwiler A: Nitric oxide and mechanisms of redox signalling: Matrix and matrix-metabolizing enzymes as prime nitric oxide targets Eur J Pharmacol 429(1-3): 279-286, 2001 10.1016/ S0014-2999(01)01326-7
20. Yoon SO, Park SJ, Yoon SY, Yun CH, Chung AS: Sustained production of H(2)O(2) activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway. J Biol Chem 277(33): 30271-30282, 2002 10.1074/jbc.M202647200
21. Zhang HJ, Zhao W, Venkataraman S, Robbins ME, Buettner GR, Kregel KC, Oberley LW: Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species. J Biol Chem 277(23): 20919-20926, 2002 10.1074/jbc.M109801200
22. Herbert B, Pitts AE, Baker SI, Hamilton SE, Wright WE, Shay JW, Corey DR: Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci USA 96(25): 14276-14281, 1999 10.1073/pnas.96.25.14276
23. Kleiner DE, Stetler-Stevenson WG: Quantitative zymography: Detection of picogram quantities of gelatinases. Anal Biochem 218: 325-329, 1994 10.1006/abio.1994.1186
24. Miranda MK, Espey MG, Wink DA: A rapid, simple spectrophotometric method for simultanous detection of nitrite and nitrate. Nitric Oxide 5(1): 62-71, 2001 10.1006/niox.2000.0319
25. Kondo S, Tanaka Y, Kondo Y, Hitomi M, Barnett GH, Ishizaka Y, Liu J, Haqqi T, Villeponteau B, Cowell JK, Barna BP: Anti-sense telomerase treatment: Induction of two distinct pathways, apoptosis and differentiation. FASEB J 12(10): 801-811, 1998 1:CAS:528:DyaK1cXktlCku7o%3D
26. Wilson MJ, Jiang A, Wiehr C, Wang X, Sinha AA, Pei D: Limited processing of pro-matrix metalloprotease-2 (gelatinase A) overexpressed by transfection in PC-3 human prostate tumor cells: Association with restricted cell surface localization of membrane-type matrix metalloproteinase-1. J Androl 25(2): 274-285, 2004 1:CAS:528:DC%2BD2cXitlarsL8%3D
27. Festuccia C, Angelucci A, Gravina GL, Villanova I, Teti A, Albini A, Bologna M, Abini A: Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells. Int J Cancer 85(3): 407-415, 2000 1:CAS:528:DC%2BD3cXmsVCguw%3D%3D
28. Dong Z, Nemeth JA, Cher ML, Palmer KC, Bright RC, Fridman R: Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells. Int J Cancer 93(4): 507-515, 2001. 1:CAS:528:DC%2BD3MXlsVCntrg%3D
29. Stearns ME, Wang M: Regulation of kinensin expression and type IV collagenase secretion in invasive human prostate PC-3 tumor sublines. Cancer Res 51: 5866-5875, 1991 1:CAS:528:DyaK3MXmslKrs7o%3D
30. Greene FG, Kitadai Y, Pettaway CA, von Eschenbach AC, Bucana CD, Fidler IJ: Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am J Pathol 150: 1571-1582, 1997 1:CAS:528:DyaK2sXjtlertLg%3D
31. Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, Jackson G, Harper J, Tamvakopoulos G, Moses MA: Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci USA 97(8): 3884-3889, 2000 1:CAS:528:DC%2BD3cXislSgsbs%3D
32. Martens JW, Sieuwerts AM, Bolt-deVries J, Bosma PT, Swiggers SJ, Klijn JG, Foekens JA: Aging of stromal-derived human breast fibroblasts might contribute to breast cancer progression. Thromb Haemost 89(2): 393-404, 2003 1:CAS:528:DC%2BD3sXhsVOgt7Y%3D
33. Dreher D, Junod AF: Role of oxygen free radicals in cancer development. Eur J Cancer 32A(1): 30-38, 1996 1:CAS:528:DyaK28XitlKqsbo%3D
34. Toyokuni S, Okamoto K, Yodoi J, Hiai H: Persistent oxidative stress in cancer. FEBS Lett 358(1): 1-3, 1995 1:CAS:528:DyaK2MXjsFanur4%3D
35. Liu DY, Peng ZH, Qiu GQ, Zhou CZ: Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis. World J Gastroenterol 9(8): 1859-1862, 2003 1:CAS:528:DC%2BD3sXnsVyqsLw%3D
36. von Zglinicki T, Zhu H, Fu W, Mattson MP: Oxidative stress shortens telomeres. Trends Biochem Sci 27(7): 339-344, 2002 1:CAS:528:DC%2BD38XltFahsbs%3D
37. Haendeler J, Hoffmann J, Brandes RP, Zeiher AM, Dimmeler S: Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol Cell Biol 23(13): 4598-4610, 2003 1:CAS:528:DC%2BD3sXltVSit7k%3D
38. Nelson KK, Melendez JA: Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med 37(6): 768-784, 2004 1:CAS:528:DC%2BD2cXmsVGgsLc%3D
39. Xiang H, Wang J, Mao YW, Li DW: HTR can function with rabbit telomerase RNA: Regulation of gene expression and attenuation of apoptosis. Biochem Biophys Res Commun 278(3): 503-510, 2000 1:CAS:528:DC%2BD3cXotlalt78%3D
40. Crawford HC, Matrisian LM: Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 49(1-3): 20-37, 1996 1:CAS:528:DyaK28XjvVGjtb4%3D
41. Laderoute KR, Calaoagan JM, Knapp AM, Mendonca HL, Johnson RS: C-jun cooperates with SV40 T-antigen to sustain MMP-2 expression in immortalized cells. Biochem Biophys Res Commun 284(5): 1134-1139, 2001 1:CAS:528:DC%2BD3MXksVKjt7w%3D
42. Lin CW, Georgescu HI, Evans CH: The role of AP-1 in matrix metalloproteinase gene expression. Agents Actions 39(Spec No): C215-C218, 1993 1:CAS:528:DyaK2cXitFel
43. Rupec RA, Baeuerle PA: The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-kappa B. Eur J Biochem 234(2): 632-640, 1995 1:CAS:528:DyaK2MXhtVSktbfN
44. Seimiya H, Sawada H, Muramatsu Y, Shimizu M, Ohko K, Yamane K, Tsuruo T: Involvement of 14-3-3 proteins in nuclear localization of telomerase. EMBO J 19(11): 2652-2661, 2000 1:CAS:528:DC%2BD3cXkslantrY%3D
45. Kelland LR: Telomerase: Biology and phase I trials. Lancet Oncol 2(2): 95-102, 2001 1:CAS:528:DC%2BD3MXhsFajurw%3D
46. Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartorelli AC, Stein CA, Nichols G, Khaled Z, Telang NT, Narayanan R: Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 92(26): 12343-12346, 1995 1:CAS:528:DyaK28Xhtl2mtA%3D%3D